Copyright Reports & Markets. All rights reserved.

Global Microbial CDMO Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Microbial CDMO Service by Type
    • 1.3.1 Overview: Global Microbial CDMO Service Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Microbial CDMO Service Consumption Value Market Share by Type in 2023
    • 1.3.3 Fermentation Scale-Up
    • 1.3.4 cGMP Manufacturing
    • 1.3.5 Other
  • 1.4 Global Microbial CDMO Service Market by Application
    • 1.4.1 Overview: Global Microbial CDMO Service Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 SMBs
    • 1.4.3 Large Companies
  • 1.5 Global Microbial CDMO Service Market Size & Forecast
  • 1.6 Global Microbial CDMO Service Market Size and Forecast by Region
    • 1.6.1 Global Microbial CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Microbial CDMO Service Market Size by Region, (2019-2030)
    • 1.6.3 North America Microbial CDMO Service Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Microbial CDMO Service Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Microbial CDMO Service Market Size and Prospect (2019-2030)
    • 1.6.6 South America Microbial CDMO Service Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Microbial CDMO Service Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Lonza
    • 2.1.1 Lonza Details
    • 2.1.2 Lonza Major Business
    • 2.1.3 Lonza Microbial CDMO Service Product and Solutions
    • 2.1.4 Lonza Microbial CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Lonza Recent Developments and Future Plans
  • 2.2 AGC Biologics
    • 2.2.1 AGC Biologics Details
    • 2.2.2 AGC Biologics Major Business
    • 2.2.3 AGC Biologics Microbial CDMO Service Product and Solutions
    • 2.2.4 AGC Biologics Microbial CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 AGC Biologics Recent Developments and Future Plans
  • 2.3 FUJIFILM Diosynth Biotechnologies
    • 2.3.1 FUJIFILM Diosynth Biotechnologies Details
    • 2.3.2 FUJIFILM Diosynth Biotechnologies Major Business
    • 2.3.3 FUJIFILM Diosynth Biotechnologies Microbial CDMO Service Product and Solutions
    • 2.3.4 FUJIFILM Diosynth Biotechnologies Microbial CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
  • 2.4 Laurus Bio
    • 2.4.1 Laurus Bio Details
    • 2.4.2 Laurus Bio Major Business
    • 2.4.3 Laurus Bio Microbial CDMO Service Product and Solutions
    • 2.4.4 Laurus Bio Microbial CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Laurus Bio Recent Developments and Future Plans
  • 2.5 BOC Sciences
    • 2.5.1 BOC Sciences Details
    • 2.5.2 BOC Sciences Major Business
    • 2.5.3 BOC Sciences Microbial CDMO Service Product and Solutions
    • 2.5.4 BOC Sciences Microbial CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 BOC Sciences Recent Developments and Future Plans
  • 2.6 AbbVie
    • 2.6.1 AbbVie Details
    • 2.6.2 AbbVie Major Business
    • 2.6.3 AbbVie Microbial CDMO Service Product and Solutions
    • 2.6.4 AbbVie Microbial CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 AbbVie Recent Developments and Future Plans
  • 2.7 Cytovance Biologics
    • 2.7.1 Cytovance Biologics Details
    • 2.7.2 Cytovance Biologics Major Business
    • 2.7.3 Cytovance Biologics Microbial CDMO Service Product and Solutions
    • 2.7.4 Cytovance Biologics Microbial CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Cytovance Biologics Recent Developments and Future Plans
  • 2.8 ADL Biopharma
    • 2.8.1 ADL Biopharma Details
    • 2.8.2 ADL Biopharma Major Business
    • 2.8.3 ADL Biopharma Microbial CDMO Service Product and Solutions
    • 2.8.4 ADL Biopharma Microbial CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 ADL Biopharma Recent Developments and Future Plans
  • 2.9 EUROAPI
    • 2.9.1 EUROAPI Details
    • 2.9.2 EUROAPI Major Business
    • 2.9.3 EUROAPI Microbial CDMO Service Product and Solutions
    • 2.9.4 EUROAPI Microbial CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 EUROAPI Recent Developments and Future Plans
  • 2.10 KBI Biopharma
    • 2.10.1 KBI Biopharma Details
    • 2.10.2 KBI Biopharma Major Business
    • 2.10.3 KBI Biopharma Microbial CDMO Service Product and Solutions
    • 2.10.4 KBI Biopharma Microbial CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 KBI Biopharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Microbial CDMO Service Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Microbial CDMO Service by Company Revenue
    • 3.2.2 Top 3 Microbial CDMO Service Players Market Share in 2023
    • 3.2.3 Top 6 Microbial CDMO Service Players Market Share in 2023
  • 3.3 Microbial CDMO Service Market: Overall Company Footprint Analysis
    • 3.3.1 Microbial CDMO Service Market: Region Footprint
    • 3.3.2 Microbial CDMO Service Market: Company Product Type Footprint
    • 3.3.3 Microbial CDMO Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Microbial CDMO Service Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Microbial CDMO Service Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Microbial CDMO Service Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Microbial CDMO Service Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Microbial CDMO Service Consumption Value by Type (2019-2030)
  • 6.2 North America Microbial CDMO Service Market Size by Application (2019-2030)
  • 6.3 North America Microbial CDMO Service Market Size by Country
    • 6.3.1 North America Microbial CDMO Service Consumption Value by Country (2019-2030)
    • 6.3.2 United States Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Microbial CDMO Service Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Microbial CDMO Service Consumption Value by Type (2019-2030)
  • 7.2 Europe Microbial CDMO Service Consumption Value by Application (2019-2030)
  • 7.3 Europe Microbial CDMO Service Market Size by Country
    • 7.3.1 Europe Microbial CDMO Service Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 7.3.3 France Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Microbial CDMO Service Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Microbial CDMO Service Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Microbial CDMO Service Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Microbial CDMO Service Market Size by Region
    • 8.3.1 Asia-Pacific Microbial CDMO Service Consumption Value by Region (2019-2030)
    • 8.3.2 China Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 8.3.5 India Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Microbial CDMO Service Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Microbial CDMO Service Consumption Value by Type (2019-2030)
  • 9.2 South America Microbial CDMO Service Consumption Value by Application (2019-2030)
  • 9.3 South America Microbial CDMO Service Market Size by Country
    • 9.3.1 South America Microbial CDMO Service Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Microbial CDMO Service Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Microbial CDMO Service Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Microbial CDMO Service Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Microbial CDMO Service Market Size by Country
    • 10.3.1 Middle East & Africa Microbial CDMO Service Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Microbial CDMO Service Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Microbial CDMO Service Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Microbial CDMO Service Market Drivers
  • 11.2 Microbial CDMO Service Market Restraints
  • 11.3 Microbial CDMO Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Microbial CDMO Service Industry Chain
  • 12.2 Microbial CDMO Service Upstream Analysis
  • 12.3 Microbial CDMO Service Midstream Analysis
  • 12.4 Microbial CDMO Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Microbial CDMO Service market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Microbial CDMO Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Microbial CDMO Service market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Microbial CDMO Service market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Microbial CDMO Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Microbial CDMO Service market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Microbial CDMO Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Microbial CDMO Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, AGC Biologics, FUJIFILM Diosynth Biotechnologies, Laurus Bio, BOC Sciences, AbbVie, Cytovance Biologics, ADL Biopharma, EUROAPI, KBI Biopharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Microbial CDMO Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Microbial CDMO Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Fermentation Scale-Up
    cGMP Manufacturing
    Other
    Market segment by Application
    SMBs
    Large Companies
    Market segment by players, this report covers
    Lonza
    AGC Biologics
    FUJIFILM Diosynth Biotechnologies
    Laurus Bio
    BOC Sciences
    AbbVie
    Cytovance Biologics
    ADL Biopharma
    EUROAPI
    KBI Biopharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Microbial CDMO Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Microbial CDMO Service, with revenue, gross margin, and global market share of Microbial CDMO Service from 2019 to 2024.
    Chapter 3, the Microbial CDMO Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Microbial CDMO Service market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Microbial CDMO Service.
    Chapter 13, to describe Microbial CDMO Service research findings and conclusion.

    Buy now